After the researchers have left the playground;Nadat de onder-zoekers het veld hebben verlaten

Tijdschrift voor Psychiatrie

Volumn 49, Issue 8, 2007, Pages 525-527

  Boer, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; METHYLPHENIDATE; CENTRAL STIMULANT AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD PSYCHIATRY; DRUG EFFECT; EDITORIAL; HEALTH CENTER; HUMAN; HYPERKINESIA; MEDICAL PRACTICE; MEDICAL RESEARCH; MENTAL HEALTH; PSYCHOPHARMACOLOGY; CHILD; NETHERLANDS; PRACTICE GUIDELINE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HUMANS; METHYLPHENIDATE; NETHERLANDS; PRACTICE GUIDELINES;

EID: 34548657951     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. American Academy of Child and Adolescent Psychiatry (2007). Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. Washington, DC: AACAP. Verkregen op 12 juli 2007 van http://www.aacap.org/galleries/PracticeParameters/ New_ADHD_Parameter.pdf.
2. Bradley, C. (1937). The Behavior of Children Receiving Benzedrine. American Journal of Psychiatry, 94, 577-585.
3. Feldman, S.A. (2002). Confessions of a managed behavioral health care physician. Journal of Developmental and Behavioral Pediatrics, 23(Suppl. 1), S51-S56.
4. MTA Cooperative Group. (1999). 14 month randomized clinical trial of treatment strategies for children with attention deficit hyperactivity disorder. Archives of General Psychiatry, 56, 1073-1086.
5. MTA Cooperative Group. (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762-769.